about
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusEffects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial)A Naive Bayes machine learning approach to risk prediction using censored, time-to-event data.Adapting machine learning techniques to censored time-to-event health record data: A general-purpose approach using inverse probability of censoring weightingPhase Angle and Impedance Ratio: Reference Cut-Points From the United States National Health and Nutrition Examination Survey 1999-2004 From Bioimpedance Spectroscopy Data.Mixed model analysis of censored longitudinal data with flexible random-effects density.Accounting for model uncertainty in estimating global burden of disease.Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record DataThe association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.Longitudinal Care Improves Cessation in Smokers Who Do Not Initially Respond to Treatment by Increasing Cessation Self-Efficacy, Satisfaction, and Readiness to Quit: A Mediated Moderation Analysis.Impact of lung transplantation on recipient quality of life: a serial, prospective, multicenter analysis through the first posttransplant year.An acute change in lung allocation score and survival after lung transplantation: a cohort study.Assessing the causal effect of organ transplantation on the distribution of residual lifetime.Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol.Covariate selection with group lasso and doubly robust estimation of causal effects.Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation.Changes in cardiovascular risk factors after 5 years of implementation of a population-based program to reduce cardiovascular disease: The Heart of New Ulm Project.Estimating restricted mean treatment effects with stacked survival models.Program for lung cancer screening and tobacco cessation: Study protocol of a sequential, multiple assignment, randomized trial.Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy.Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization.Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents.Changes to polymer surface of drug-eluting stents during balloon expansion.Performance of the Net Reclassification Improvement for Non-nested Models and a Novel Percentile-based Alternative.Lung Cancer Screening and Smoking Cessation Clinical Trials: SCALE Collaboration.Do pregnancy characteristics contribute to rising childhood cancer incidence rates in the United States?Socioeconomic Status and Childhood Cancer Incidence: A Population-Based Multilevel Analysis.Evolution of Living Donor Nephrectomy at a Single Center: Long-term Outcomes With 4 Different Techniques in Greater Than 4000 Donors Over 50 Years.GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.Defining the Tipping Point in Surgical Performance for Laparoscopic Donor Nephrectomy Among Transplant Surgery Fellows: A Risk-Adjusted Cumulative Summation Learning Curve Analysis.Testing a modified perceived exertion scale for Alzheimer's disease.Causes and Timing of End-Stage Renal Disease after Living Kidney Donation.Executive function: Responses to aerobic exercise in Alzheimer's disease.Renal Consequences of Diabetes After Kidney Donation.Use of both quantitative and qualitative methods to improve assessment of resting energy expenditure equation performance in hospitalized adults.Assessing the impact of the heart of New Ulm Project on cardiovascular disease risk factors: A population-based program to reduce cardiovascular disease.Estimating the causal effect of treatment regimes for organ transplantation
P50
Q28279955-0B1BA70E-7963-45BE-A3BC-BC52DE9F6680Q30612694-16BFF557-2C73-4869-AC32-A6BF88151AEAQ30952713-642E4E3B-A1E7-43F5-B2DD-31A27EAE142AQ31060694-70961C16-4107-414D-BD11-FC551071C059Q31133200-0C5527F3-706C-4CE7-B7A6-59E36B8041F4Q34018634-B29F864E-9180-4D20-91D0-E0E5467E6D1CQ34579945-87B121E5-AA0D-4B84-9789-6F58A64E7D0BQ36332458-FB876226-CBBE-4C4C-A580-92F531237445Q36355669-D3E2B72F-729D-408B-811F-453E07BC04CEQ36457818-AA522036-DBC7-41B1-A1E0-6FD2C64CCD6AQ36457831-67B0B920-A5B6-41BD-9AEC-51AFF4BDB819Q36552501-5407C5AE-D951-4E9C-BADE-6EF095A94054Q37105996-9F5A6505-D42C-42FE-9571-4244B5EA76A9Q37285800-6282A047-E0CA-4036-A74D-551D34F6F6D9Q37397227-5A48A908-BA73-4A84-BB28-9C947E40B17FQ37576656-CE60C47A-EC43-4FEF-AA15-4E96E0DCB50EQ38715739-76B4D1BA-3337-438E-8ACF-A73735234E7CQ38729913-98740AAD-4F0A-4426-8596-1B79D537233BQ39250971-617EB35D-96B4-49C4-AC86-6139D95C8DF6Q39765986-4C9F0897-3A56-499F-8985-6D5E0D790185Q39953870-97860B93-1F70-4BDA-98E2-6B3DD975537EQ40131617-0C660D0A-6305-4218-99B6-BEC39295EFE3Q40155391-36ACB372-CBE9-487F-B775-AFFCF3BDAE95Q40256572-AE22E498-B865-4E3A-B2F0-3F5F2465E8EEQ46716233-A145BDB6-4B53-4E15-90D9-D74542273819Q47145442-2D53849D-2EC7-49B9-BEAB-E42B6980B206Q47205309-F86214B4-072D-4684-AE44-98EF0A9A4C33Q47251963-010A31AF-10CE-43D2-8184-314130D5C688Q47436213-73521401-0333-4D7E-9003-50A7122FDAAAQ47653008-D5CE8083-C473-4E81-B92A-21345870C390Q47809051-BEBF2FD3-8B12-4C0A-865E-89574D0EFC18Q47860392-7C70E33C-6F6A-4627-9EAF-D7142267CB39Q48112521-60F3B1E5-EA26-41D8-AE9F-F69A3F31B568Q48147802-999468E3-FC7C-4949-973D-7953EA95398AQ49710992-5A4D91EC-E242-46AF-A2DF-2646C679ACB2Q50068607-FF9B3326-86CE-4C2D-BD71-DAE93DFF52A6Q50543710-960A169F-643B-4B32-AD95-B8B04C1835E4Q52382015-3672A0CB-7C9E-4817-9C02-CC4608EEB4AFQ52596329-43719C87-ED2B-4324-893F-EA958DFDDC75Q57176531-3B5D30F0-329B-4039-9F5E-CF1C73595FA4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David M Vock
@fr
David M. Vock
@en
David M. Vock
@es
David M. Vock
@nl
David M. Vock
@sl
type
label
David M Vock
@fr
David M. Vock
@en
David M. Vock
@es
David M. Vock
@nl
David M. Vock
@sl
prefLabel
David M Vock
@fr
David M. Vock
@en
David M. Vock
@es
David M. Vock
@nl
David M. Vock
@sl
P101
P1153
36437633400
P21
P31
P3835
david-vock
P496
0000-0002-5459-9579